Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
07 2019
Historique:
received: 22 04 2018
revised: 23 01 2019
accepted: 31 01 2019
pubmed: 29 4 2019
medline: 22 9 2020
entrez: 29 4 2019
Statut: ppublish

Résumé

Beside the classical flat parietal epithelial cells (PECs), we investigated proximal tubular epithelial-like cells, a neglected subgroup of PECs. These cells, termed cuboidal PECs, make up the most proximal part of the proximal tubule and may also line parts of Bowman's capsule. Additionally, a third intermediate PEC subgroup was identified at the junction between the flat and cuboidal PEC subgroups at the tubular orifice. The transgenic mouse line PEC-rtTA labeled all three PEC subgroups. Here we show that the inducible Pax8-rtTA mouse line specifically labeled only cuboidal and intermediate PECs, but not flat PECs. In aging Pax8-rtTA mice, cell fate mapping showed no evidence for significant transdifferentiation from flat PECs to cuboidal or intermediate PECs or vice versa. In murine glomerular disease models of crescentic glomerulonephritis, and focal segmental glomerulosclerosis (FSGS), intermediate PECs became more numerous. These intermediate PECs preferentially expressed activation markers CD44 and Ki-67, suggesting that this subgroup of PECs was activated more easily than the classical flat PECs. In mice with FSGS, cuboidal and intermediate PECs formed sclerotic lesions. In patients with FSGS, cells forming the tip lesions expressed markers of intermediate PECs. These novel PEC subgroups form sclerotic lesions and were more prone to cellular activation compared to the classical flat PECs in disease. Thus, colonization of Bowman's capsule by cuboidal PECs may predispose to lesion formation and chronic kidney disease. We propose that tip lesions originate from this novel subgroup of PECs in patients with FSGS.

Identifiants

pubmed: 31029503
pii: S0085-2538(19)30186-3
doi: 10.1016/j.kint.2019.01.037
pmc: PMC7292612
mid: NIHMS1587676
pii:
doi:

Substances chimiques

CD44 protein, human 0
Cd44 protein, mouse 0
Hyaluronan Receptors 0
Ki-67 Antigen 0
MKI67 protein, human 0
Mki67 protein, mouse 0
PAX8 Transcription Factor 0
Pax8 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-93

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK056942
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK080095
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

J Am Soc Nephrol. 2011 Jul;22(7):1262-74
pubmed: 21719782
J Pathol. 2000 Mar;190(4):478-83
pubmed: 10699998
J Am Soc Nephrol. 2009 Dec;20(12):2604-15
pubmed: 19917779
J Am Soc Nephrol. 2006 Sep;17(9):2443-56
pubmed: 16885410
Kidney Int. 2017 Jan;91(1):70-85
pubmed: 27678159
J Am Soc Nephrol. 2014 Apr;25(4):707-16
pubmed: 24408871
Semin Nephrol. 2014 Jul;34(4):394-403
pubmed: 25217268
Lancet. 2012 Jan 14;379(9811):165-80
pubmed: 21840587
Kidney Int. 1983 Nov;24(5):626-31
pubmed: 6663985
J Am Soc Nephrol. 2009 Feb;20(2):333-43
pubmed: 19092119
J Cell Biol. 1967 Nov;35(2):435-44
pubmed: 4861776
J Am Soc Nephrol. 2015 Dec;26(12):3162-78
pubmed: 26038526
Kidney Int. 1998 Sep;54(3):687-97
pubmed: 9734594
Nat Rev Nephrol. 2014 Mar;10(3):158-73
pubmed: 24468766
Kidney Int. 2015 Nov;88(5):990-8
pubmed: 25853334
J Am Soc Nephrol. 2004 Apr;15(4):928-39
pubmed: 15034095
Am J Pathol. 2009 Nov;175(5):1883-95
pubmed: 19834063
Clin J Am Soc Nephrol. 2012 Nov;7(11):1852-8
pubmed: 22917699
J Pathol. 2013 Apr;229(5):645-59
pubmed: 23124355
Am J Pathol. 2014 Dec;184(12):3239-48
pubmed: 25307344
J Pathol. 1995 Oct;177(2):191-9
pubmed: 7490686
Am J Kidney Dis. 2004 Feb;43(2):368-82
pubmed: 14750104
Nat Med. 2011 Sep 25;17(10):1242-50
pubmed: 21946538
Kidney Int. 2017 Apr;91(4):896-913
pubmed: 27998643
J Am Soc Nephrol. 2014 May;25(5):927-38
pubmed: 24335975
J Anat. 1993 Apr;182 ( Pt 2):177-85
pubmed: 8376192
Nat Rev Nephrol. 2018 Mar;14(3):151-164
pubmed: 29355169
Am J Pathol. 1982 Apr;107(1):92-7
pubmed: 7065126
Am J Anat. 1983 May;167(1):1-13
pubmed: 6869305
Lab Invest. 2012 Apr;92(4):499-510
pubmed: 22249313
Science. 1940 Mar 22;91(2360):299
pubmed: 17839410
Clin J Am Soc Nephrol. 2009 Nov;4(11):1747-53
pubmed: 19808230
Kidney Int. 2007 Jun;71(12):1205-14
pubmed: 17410103
Anat Embryol (Berl). 1991;184(6):605-10
pubmed: 1776706
Experientia. 1976 Dec 15;32(12):1584-5
pubmed: 798696
Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1533-8
pubmed: 24474779
J Pathol. 1984 Mar;142(3):205-20
pubmed: 6707787
Kidney Int. 2005 Mar;67(3):987-1001
pubmed: 15698437
Cell. 1987 Oct 9;51(1):21-31
pubmed: 2888537
J Am Soc Nephrol. 2014 Apr;25(4):693-705
pubmed: 24408873
J Am Soc Nephrol. 2007 Dec;18(12):3128-38
pubmed: 17978305
Am J Pathol. 2011 Feb;178(2):828-37
pubmed: 21281815
J Am Soc Nephrol. 2016 Jun;27(6):1650-64
pubmed: 26453615
Kidney Int. 2016 Apr;89(4):792-808
pubmed: 26924053
J Pathol. 1990 May;161(1):47-56
pubmed: 2370598
Kidney Int. 2018 Mar;93(3):626-642
pubmed: 29276101
Physiol Genomics. 2011 Feb 11;43(3):161-73
pubmed: 21081658

Auteurs

Christoph Kuppe (C)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany. Electronic address: ckuppe@ukaachen.de.

Katja Leuchtle (K)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.

Anton Wagner (A)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.

Nazanin Kabgani (N)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.

Turgay Saritas (T)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.

Victor G Puelles (VG)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany; Cardiovascular Program, Monash Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, School of Biomedical Sciences, and Centre for Inflammatory Diseases, Monash University, Melbourne, Victoria, Australia; Department of Nephrology, Monash Health, Melbourne Australia.

Bart Smeets (B)

Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Samy Hakroush (S)

Institute of Pathology, University Medical Center, Göttingen, Germany.

Johan van der Vlag (J)

Department of Nephrology, Radboud Institute for Molecular Life Sciences, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Peter Boor (P)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany; Institute of Pathology, RWTH University of Aachen, Aachen, Germany.

Mario Schiffer (M)

Department of Nephrology and Hypertension, University of Erlangen, Erlangen, Germany.

Hermann-Josef Gröne (HJ)

Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.

Agnes Fogo (A)

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Jürgen Floege (J)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany.

Marcus Johannes Moeller (MJ)

Division of Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany. Electronic address: mmoeller@ukaachen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH